These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1867 related items for PubMed ID: 17559720
1. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Kuti EL, Baker WL, White CM. Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720 [Abstract] [Full Text] [Related]
2. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G. Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [Abstract] [Full Text] [Related]
3. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials. Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G. J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108 [Abstract] [Full Text] [Related]
5. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Bangalore S, Parkar S, Grossman E, Messerli FH. Am J Cardiol; 2007 Oct 15; 100(8):1254-62. PubMed ID: 17920367 [Abstract] [Full Text] [Related]
7. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study. Liou YS, Ma T, Tien L, Lin CM, Jong GP. Hypertens Res; 2009 Jun 15; 32(6):496-9. PubMed ID: 19390541 [Abstract] [Full Text] [Related]
9. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. N Engl J Med; 2000 Mar 30; 342(13):905-12. PubMed ID: 10738048 [Abstract] [Full Text] [Related]
10. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future? Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM. Blood Press; 2007 Mar 30; 16(1):6-12. PubMed ID: 17453746 [Abstract] [Full Text] [Related]
11. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis. Sarafidis PA, Stafylas PC, Kanaki AI, Lasaridis AN. Am J Hypertens; 2008 Aug 30; 21(8):922-9. PubMed ID: 18535536 [Abstract] [Full Text] [Related]
13. Blood pressure reduction is not the only determinant of outcome. Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR. Circulation; 2006 Jun 13; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926 [No Abstract] [Full Text] [Related]
14. [Hypertension 2007-2008]. Chatzikyrkou C, Menne J, Haller H. Med Klin (Munich); 2009 Aug 13; 104(8):614-21. PubMed ID: 19701732 [Abstract] [Full Text] [Related]
16. Long-term safety of antihypertensive therapy. Grossman E, Messerli FH. Prog Cardiovasc Dis; 2006 Aug 13; 49(1):16-25. PubMed ID: 16867847 [Abstract] [Full Text] [Related]
17. [Diabetes prevention in hypertensive patients]. Girerd X, Hansel B, Villeneuve F, Dourmap C. Arch Mal Coeur Vaiss; 2007 Feb 13; 100(2):139-43. PubMed ID: 17474500 [Abstract] [Full Text] [Related]
18. Current recommendations for the treatment of hypertension: are they still valid? Moser M. J Hypertens Suppl; 2002 Feb 13; 20(1):S3-10. PubMed ID: 11996197 [Abstract] [Full Text] [Related]
19. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, Paolillo S, Petretta A, Chiariello M. J Hypertens; 2009 Jun 13; 27(6):1136-51. PubMed ID: 19451836 [Abstract] [Full Text] [Related]